Quick Answer
Wave Life Sciences Ltd. reported Operating Income of -$215.38 million for fiscal year 2025.
Wave Life Sciences Ltd. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$215.38M | -95.1% |
| 2024 | -$110.40M | -62.4% |
| 2023 | -$68.00M | +58.2% |
| 2022 | -$162.72M | -28.1% |
| 2021 | -$127.02M | +17.2% |
| 2020 | -$153.38M | +26.4% |
| 2019 | -$208.32M | -30.6% |
| 2018 | -$159.52M | -55.8% |
| 2017 | -$102.39M | -83.8% |
| 2016 | -$55.72M | -188.7% |
| 2015 | -$19.30M | -257.8% |
| 2014 | -$5.39M | -50.9% |
| 2013 | -$3.57M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$56.35M | +11.8% | -6.8% |
| June 30, 2025 | -$52.76M | -50.8% | -5.9% |
| March 31, 2025 | -$49.80M | -44.5% | +22.1% |
| September 30, 2024 | -$63.91M | -1538.2% | -82.6% |
| June 30, 2024 | -$35.00M | -49.1% | -1.6% |
| March 31, 2024 | -$34.46M | -13.8% | -875.4% |
| September 30, 2023 | $4.44M | +111.4% | +118.9% |
| June 30, 2023 | -$23.47M | +44.3% | +22.5% |
- Wave Life Sciences Ltd. showed a decrease of -95.1% in Operating Income compared to the prior fiscal year.
- Over the 2013–2025 period, Wave Life Sciences Ltd.’s operating income has declined by 5926.4% (from -$3.57 million to -$215.38 million).
- The most recent figure is from Wave Life Sciences Ltd.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: